Zydus Lifesciences announces Rs 1100 crore buyback at Rs 1260 per share

Corporate Actions View source PDF Explain this filing

ZYDUSLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.8%Reaction day

₹1089.00

prior close

₹1082.00

announcement price

After-mkt

timing

Nifty 100market · index membership as recorded later (tracked since Jun 2026)+0.4%-1.2% vs market

Pharmaceuticals peers, median of 164sector-0.3%-0.6% vs sector

On the reaction day the stock moved 1.2 pts less than Nifty 100 and 0.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.2

10m

-0.1

15m

+0.5

30m

+0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.8+0.4-1.2-0.3-0.6

Next day

-1.2+0.1-1.3-0.3-0.9

-0.5+0.1-0.6-0.3-0.2

+0.1+0.0+0.1+0.3-0.1

-0.2-1.2+1.0-0.7+0.6

+1.3-0.5+1.8+0.4+0.9

+1.7-1.2+2.9-0.5+2.3

15d

+2.1+2.1+0.0+4.7-2.5

+1.2+3.4-2.3+6.0-4.8

+2.4+6.1-3.7+6.4-3.9

+6.0+2.7+3.3+7.6-1.6

UpDownMarket · Nifty 100Sector · Pharmaceuticals peers, median of 164Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Zydus Lifesciences has announced a buyback of up to 87.30 lakh equity shares (0.87 percent of paid-up capital) at Rs 1,260 per share, aggregating up to Rs 1,100 crore. The buyback price was revised upward from the original Rs 1,150 per share approved on May 19, 2026. The buyback will run from June 4, 2026 to June 10, 2026 via the tender offer route. Record date is May 29, 2026. Small shareholders get a reserved quota with higher entitlement ratio.

Likely market impact

Shareholders can tender shares up to entitlement at Rs 1,260. Buyback may support stock price near-term. Small shareholders have reserved quota.